The expression of ERα, ERβ and PR in lobular carcinomain situof the breast determined using laser microdissection and real-time PCR
- 11 March 2009
- journal article
- Published by Wiley in Histopathology
- Vol. 54 (4) , 419-427
Abstract
Aims: To determine the status of oestrogen receptor (ER) subtypes (ERα and ERβ) in lobular carcinoma in situ (LCIS) of the breast. Methods and results: Forty‐seven cases of LCIS and six cases with normal breast lobules were subjected to immunohistochemistry and evaluated for ERα, ERβ and progesterone receptor (PR) expression. mRNA for ERα, ERβ1 and ERβ2 were quantified in LCIS and normal lobules using laser microdissection coupled with real‐time polymerase chain reaction. LCIS showed a higher level of steroid receptor protein expression than normal lobules. There was no difference in ERβ1 gene or ERβ protein expression between normal lobules, pure LCIS, or LCIS associated with invasive breast cancer. No significant difference in expression of either ERα or ERβ was found between pure LCIS and LCIS associated with invasive cancer. However, PR was significantly lower in those cases of LCIS with associated invasive than in those without synchronous invasive disease. Conclusions: Increased expression of steroid receptors in LCIS suggests their possible role in the biology of LCIS and, for PR, could influence the predisposition of women diagnosed with LCIS to develop invasive breast carcinoma.Keywords
This publication has 33 references indexed in Scilit:
- The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?European Journal of Cancer, 2006
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysesInternational Journal of Cancer, 2005
- Biomarker profile and genetic abnormalities in lobular carcinoma in situBreast Cancer Research and Treatment, 2005
- The Ah receptor inhibits estrogen-induced estrogen receptor β in breast cancer cellsBiochemical and Biophysical Research Communications, 2004
- Loss of CD59 expression in breast tumours correlates with poor survivalThe Journal of Pathology, 2003
- Estrogen receptor beta in breast cancer.Endocrine-Related Cancer, 2002
- Evaluation of oestrogen receptor β wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancersEuropean Journal of Cancer, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breastEuropean Journal of Cancer, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996